Contents
Academy · Research Data, Analytics & AI · Respiratory Epidemiology Study Types
Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries
A 2024 scoping review of chronic respiratory disease in low- and middle-income countries pooled 52 studies and 244,004 participants. Its evidence base, drawn overwhelmingly from sub-Saharan Africa, illustrates how the choice of study design shapes which risk factors a body of respiratory research is able to detect.
Respiratory disease research draws on the same basic epidemiological toolkit used elsewhere in medicine, cross-sectional surveys, case-control studies, cohort studies, and, less often, randomized trials of preventive interventions, but the exposures of greatest interest in this field, air pollution, occupational dust, smoking, and indoor cooking fuel, lend themselves to some designs more than others. A 2024 scoping review of chronic respiratory disease in low- and middle-income countries (LMICs) illustrates this pattern: of 52 studies it pooled, covering 244,004 participants, the evidence base skewed heavily toward observational designs capturing exposure-outcome associations rather than toward trials, and toward certain regions and exposure types over others1.
Learning objectives
- The main epidemiological study designs used in respiratory research and what each is suited to detect
- What a 2024 scoping review's regional and exposure-type pattern reveals about which designs dominate this field
- Why household and occupational exposures required different study approaches than outdoor air pollution
Common misconceptions
- “Respiratory epidemiology research is conducted fairly evenly across world regions and exposure types.” A 2024 scoping review found that of the 52 studies it included, 43 (83%) were conducted in sub-Saharan Africa and 16 (31%, with some overlap) in Asia, and that household and occupational exposures dominated the sub-Saharan African evidence base while industrial and urban air pollution dominated findings from other low- and middle-income regions, a regional and exposure skew that shapes what the pooled evidence can and cannot say.
The main epidemiological designs used in respiratory research
Cross-sectional studies measure exposure and respiratory outcomes, spirometry results, symptom questionnaires, or diagnosed conditions, at a single point in time across a population, making them well suited to estimating how common a condition or exposure is, but poorly suited to establishing which came first. Case-control studies recruit people who already have a respiratory outcome, such as diagnosed COPD, and compare their past exposures against a comparison group without the condition, which is efficient for studying rare outcomes but depends heavily on accurate recall of past exposure, such as years of occupational dust exposure or indoor cooking-fuel use. Cohort studies follow an exposed and an unexposed group forward in time, tracking who develops a respiratory outcome, which allows a clearer temporal sequence (exposure before outcome) but requires long follow-up and larger sample sizes, particularly for outcomes like COPD that develop over decades. Randomized trials, less common in this space because many respiratory exposures, like air pollution or occupational dust, cannot ethically or practically be randomized to individuals, are more often used to test interventions, a cleaner cookstove program, a smoking-cessation intervention, rather than to study the original exposure-disease relationship itself.
A further, often underused design in respiratory research specifically is the nested case-control study, which draws its cases and controls from within an already-assembled cohort rather than recruiting a fresh comparison group from the general population. This hybrid approach captures much of a cohort study's advantage in establishing exposure before outcome, since exposure data was collected prospectively for the whole cohort before any cases developed, while retaining much of a case-control study's efficiency, since detailed, often expensive exposure measurements (such as biomarker analysis or detailed occupational history coding) only need to be completed for the smaller subset of cases and matched controls rather than the entire cohort. For a long-latency respiratory outcome like COPD or occupational pneumoconiosis, whose global incidence trends are themselves tracked through exactly this kind of long-horizon epidemiological surveillance8, where a full cohort might need to be followed for twenty or more years before enough cases accumulate to support a stable statistical estimate, nesting a case-control analysis within that cohort once enough cases have developed is often the only practical way to combine prospective exposure measurement with a feasible research budget and timeline.
Ecological studies also merit specific consideration, since they are common in respiratory research on ambient air pollution but carry a distinct interpretive limitation that should be stated explicitly. An ecological design compares population-level exposure, average measured air pollution in a city or region, against population-level outcome rates, hospital admissions or mortality for respiratory conditions in that same area, without linking individual exposure to individual outcome at all. This makes ecological studies efficient for detecting broad, population-level associations using routinely collected monitoring and health-record data, but it leaves them vulnerable to the ecological fallacy7, the risk that a population-level association does not hold, or even reverses, at the individual level, because the individuals most exposed to the pollution are not necessarily the same individuals experiencing the outcome being measured. For this reason, ecological findings in respiratory research are typically treated as hypothesis-generating rather than confirmatory, useful for identifying a signal worth following up with an individual-level cohort or case-control design rather than as a standalone basis for establishing an individual-level causal relationship, a caution broadly consistent with how the Bradford Hill considerations treat any single, isolated association as only one input into a wider causal judgment10.
Findings of a 2024 scoping review on the existing evidence base
Boutros and colleagues conducted a scoping review following PRISMA-ScR guidelines2, searching PubMed, Embase, and Scopus for studies on chronic respiratory disease risk factors, burden, and interventions in low- and middle-income countries published between 2011 and 20241. They identified 52 eligible studies covering 244,004 participants in total1. The regional distribution of this evidence base was sharply skewed: 43 studies (83%) were conducted in sub-Saharan Africa, and 16 (31%, reflecting some studies spanning multiple regions) were conducted in Asia1. The exposure focus also differed by region: household and occupational exposures, indoor cooking-fuel smoke and workplace dust and fumes, were the most severe and most studied risk factors in the sub-Saharan African literature, while other low- and middle-income regions more often reported on industrial and urban air pollution1, a split broadly consistent with global burden-of-disease estimates that attribute a disproportionate share of household air pollution exposure specifically to lower-income settings5, while ambient, outdoor air pollution exposure is tracked separately by the World Health Organization as a distinct global health risk6. The review also found that the burden of chronic respiratory disease in these settings carries a social and economic dimension beyond the clinical outcome itself, citing stigma, social exclusion, and financial strain as recurring themes, and it identified climate change as a factor the included literature increasingly expects to worsen respiratory disease risk, with effects the authors describe as varying by region1.
Dependence of study design choice on the exposure under investigation
The regional and exposure pattern in the 2024 review is partly a product of which study designs are practical for which exposures. Household air pollution from cooking fuel is a chronic, relatively stable, individually measurable exposure, which makes it tractable for cohort and cross-sectional designs within a single community, explaining why it dominates the sub-Saharan African literature the review captured. Outdoor, urban, and industrial air pollution, by contrast, is typically measured at the population or city level using ambient monitoring data rather than individual exposure assessment, which favors ecological and time-series designs that compare pollution levels against population-level respiratory outcomes over time, a design better suited to the urban settings more common in the non-African low- and middle-income regions the review covered. Occupational exposures sit in between: they are individually measurable, as household exposures are, but often require case-control designs when the respiratory outcome of interest, such as occupational COPD or pneumoconiosis, is uncommon enough that a prospective cohort would need an impractically large sample to capture enough cases. Recognizing which design fits which exposure has practical significance; the 2024 review's own regional skew is, in part, a visible consequence of which designs researchers in different settings had the infrastructure and funding to run, which matters directly when interpreting how complete or representative this evidence base is.
A further design consideration specific to respiratory research is the choice between symptom-based and lung-function-based outcome measurement, which cuts across all four core epidemiological designs described above. Many respiratory epidemiological studies rely on standardized symptom questionnaires, validated instruments asking about cough, wheeze, and breathlessness, because they are inexpensive to administer at scale and do not require specialized equipment, making them practical for cross-sectional and case-control studies conducted in resource-limited settings, including much of the sub-Saharan African literature the 2024 scoping review captured, a reporting consistency the STROBE statement specifically asks observational studies of this kind to make explicit9. Other studies instead use objective lung-function testing, spirometry measuring forced expiratory volume and forced vital capacity, which gives a more direct, quantitative measure of airflow limitation but requires trained personnel, calibrated equipment, and a degree of patient cooperation that is harder to achieve at the scale a large cross-sectional survey or cohort study might need. A study's choice between these two measurement approaches is itself a design decision with downstream consequences: symptom-based outcomes can be reported more consistently across low-resource settings but are more subjective and potentially influenced by a respondent's own awareness of their exposure, while spirometry-based outcomes are more objective but concentrate the available evidence in settings with greater research infrastructure, reinforcing the same regional skew the 2024 review documents.
Surveillance-style repeated cross-sectional studies, conducted at intervals using a consistent sampling methodology, occupy an intermediate position between a single cross-sectional snapshot and a full prospective cohort, and they are particularly well suited to tracking population-level trends in respiratory disease prevalence over time without the cost and attrition risk of following the same individuals for years. This design is commonly used for tracking asthma4 and COPD3 prevalence trends at a national level, and its main limitation mirrors the general cross-sectional limitation: because each wave samples a new, independent group of people, it can show that prevalence is rising or falling across the population but cannot, by itself, distinguish whether that shift reflects new cases, changes in survival among existing cases, or changes in diagnostic practice and awareness over the same period, a distinction that typically requires a linked cohort or administrative-record design to resolve.
Key points
Key points
Respiratory epidemiology draws on the same core designs as the rest of epidemiology, but a 2024 scoping review indicates that the existing evidence base is heavily skewed by region and exposure type: household and occupational studies are concentrated in sub-Saharan Africa and industrial and urban pollution studies elsewhere, a pattern associated with which designs are practical for which exposures.
Practical application
Practical application
- The study design should be matched to the most appropriate method of exposure measurement. Individually measurable, stable exposures like household cooking fuel fit cohort or cross-sectional designs; population-level exposures like urban air pollution fit ecological or time-series designs instead.
- Regional and exposure skew in the existing literature should be assessed before findings are generalized. The 2024 review found 83% of its included studies came from sub-Saharan Africa, so conclusions about household-exposure risk are not automatically generalizable to a different region's dominant exposure profile.
- A case-control design is appropriate when the respiratory outcome is uncommon and exposure history can be reliably recalled. This fits occupational exposure studies especially well, where a prospective cohort would often need an impractically large sample to capture enough cases.
Frequently asked questions
It depends on the type of pollution: household and occupational exposures, which are individually measurable, favor cohort and cross-sectional designs, while outdoor or industrial pollution more often relies on ecological or time-series designs using population-level monitoring data.
Exposures like air pollution and occupational dust generally cannot be ethically or practically randomized to individuals, so trials in this space are more often used to test interventions, such as cleaner cookstoves, rather than the original exposure-disease relationship.
No; it means the existing literature the review could find and include was concentrated there, likely reflecting where household-exposure research infrastructure and funding were available, not that the region's disease burden is disproportionately represented relative to need.
The included literature increasingly links climate change to worsening respiratory disease risk, with the review noting that the specific effects vary by region, though climate exposure itself is harder to study with the individual-level designs common in the reviewed literature.
References
- Boutros P, Kassem N, Boudo V, et al. Understanding the Risk Factors, Burden, and Interventions for Chronic Respiratory Diseases in Low- and Middle-Income Countries: A Scoping Review. Public Health Rev. 2024;45:1607339. read 10 October 2026. View on Public Health Reviews
- Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-473. read 10 October 2026. View on Annals of Internal Medicine
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. read 10 October 2026. View GOLD report
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. read 10 October 2026. View GINA report
- GBD 2021 Risk Factors Collaborators. Global, regional, and national burden of household air pollution, 1990-2021. read 10 October 2026. View on PMC
- World Health Organization. Air quality, energy and health: health impacts of exposure to ambient air pollution. read 10 October 2026. View on WHO
- Individuals are not small groups: the ecological fallacy in epidemiological research. read 10 October 2026. View on PMC
- Global, regional, and national trends in the incidence of pneumoconiosis among populations aged 20 and above from 1990 to 2021. read 10 October 2026. View on PMC
- von Elm E, Altman DG, Egger M, et al. The STROBE statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. read 10 October 2026. View on The BMJ
- The missed lessons of Sir Austin Bradford Hill. read 10 October 2026. View on PMC
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries. Pubrica. https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/
Pubrica Academy. “Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries.” Pubrica, 10 Oct. 2026, pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/.
Pubrica Academy (2026) Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries. Pubrica. Available at: https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/ (Accessed: 15 October 2026).
Pubrica Academy. “Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries.” Pubrica. October 10, 2026. https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/
Pubrica Academy, ‘Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/> accessed 15 October 2026.
Pubrica Academy. Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/
Pubrica Academy, “Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/
@misc{/la_epidemiological_studies_respiratory_research_2026,
author = {{Pubrica Academy}},
title = {Epidemiological Study Designs in Respiratory Research: Evidence from Low- and Middle-Income Countries},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/systematic-review/different-epidemiological-studies-in-respiratory-research/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Respiratory Study Design Selection Guide
This checklist supports the matching of a respiratory research question to the appropriate epidemiological design.
[ ] Identified whether the exposure is individually measurable (household/occupational) or population-level (urban/industrial air pollution) [ ] Checked whether the respiratory outcome is common enough for a cohort design or rare enough to need case-control [ ] Confirmed whether a cross-sectional snapshot is sufficient or whether temporal sequence (cohort) is required [ ] Checked the regional representativeness of comparable existing literature before generalizing [ ] Considered whether an intervention trial (e.g., cookstove or cessation program) better fits the research question than an observational exposure study
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica's epidemiology research design service helps match respiratory research questions to the study design best suited to the exposure type, and checks how representative comparable published evidence is before a study is finalized.